This inventor holds 1 USPTO granted patent. Top assignee: Ryvu Therapeutics S.a.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: **The Innovative Journey of Magdalena Mroczkowska**
Introduction
Magdalena Mroczkowska, based in Wizna, Poland, is a prominent inventor known for her groundbreaking contributions to the field of biotechnology. With a focus on medicinal chemistry and novel therapeutic approaches, she has made a significant impact in the development of treatments targeting critical health issues.
Latest Patents
Magdalena holds a patent for "Modulators of stimulator of interferon genes (STING)." This patent encompasses compounds that are useful as modulators of STING (Stimulator of Interferon Genes), aiming to provide therapeutic benefits. The invention covers various forms, including salts, stereoisomers, tautomers, or N-oxides of the compounds, emphasizing their value as medicaments and in pharmaceutical compositions.
Career Highlights
Currently, Magdalena Mroczkowska is associated with Ryvu Therapeutics S.A., a company known for its innovation in drug development and biotechnology. Her work there is pivotal in advancing research and potential treatments for various diseases, particularly through her patented work.
Collaborations
In her professional journey, Magdalena has collaborated with several talented individuals, including her coworker, Magdalena Izabela Zawadzka. Together, they contribute to the dynamic environment at Ryvu Therapeutics S.A., fostering innovation and developing groundbreaking therapies.
Conclusion
Magdalena Mroczkowska exemplifies the drive and creativity of modern inventors. Her patented work not only highlights her expertise but also her commitment to improving health outcomes through biotechnology. As she continues to develop new therapies, her contributions will undoubtedly influence the future of medicine and therapeutic innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile